학회지 및 논문
home > 자료실> 학회지 및 논문
- 글자크기
신약재창출을 통한 신약개발 병목 극복
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2014-08-12 | 조회수 | 1,080 |
| 출처 | Nature Medicine | ||
| 원문 | http://www.nature.com/nm/journal/v20/n6/full/nm.3595.html | ||
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks
Stephen M Strittmatter
- Nature Medicine 20, 590–591(2014) |DOI:10.1038/nm.3595
- Published online 05 June 2014
[Abstract]
The development of new therapies is an arduous, time-consuming and costly task. Furthermore, the development of many compounds runs into issues related to safety. Drug repurposing, where drugs with established safety in humans are tested and developed for efficacy in a disease other than the one for which they were developed, is gaining traction because of its potential to overcome an initial bottleneck in the drug development process. In “Bedside to Bench,” Stephen Strittmatter discusses the types of scenario in which drug repurposing may be of benefit, such as when a drug is repurposed for a new molecular target or for the same target in a different disease. In “Bench to Bedside,” Michael Pollak focuses on a recent study that suggest that biguanides that are normally used in the treatment of diabetes could have direct cyotoxic action on cancer cells with mutations in respiratory complex I. The pharmacokinetic hurdles that may need to be overcome for this to be translated to the clinic are also discussed.
신약개발은 시간과 비용이 많이 소요되기 때문에 쉽지 않으나 기존 사람에게 효능을 보인 약물이 다른 질환을 치료하는 약으로 개발 가능하다면 신약개발 초기의 병목현상을 극복할 수 있다는 내용
※ 자세한 내용은 아래 원문 URL을 이용하시기 바랍니다.
